Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
201.8 USD | -3.28% | -9.27% | -19.76% |
Apr. 17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
Apr. 12 | Penumbra, Inc. : The underdog in healthcare |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.76% | 7.81B | |
+71.87% | 12.28B | |
+15.96% | 7.19B | |
-6.87% | 5.23B | |
+4.54% | 4.94B | |
+18.62% | 4.24B | |
-25.36% | 3.97B | |
-40.48% | 2.24B | |
-4.08% | 1.92B | |
-4.68% | 1.71B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Transcript : Penumbra, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-14-2021 11